share_log

Wells Fargo Maintains Equal-Weight on Nevro, Lowers Price Target to $13

Wells Fargo Maintains Equal-Weight on Nevro, Lowers Price Target to $13

富国银行维持对Nevro的同等权重,将目标股价下调至13美元
Benzinga ·  05/08 10:42

Wells Fargo analyst Nathan Treybeck maintains Nevro (NYSE:NVRO) with a Equal-Weight and lowers the price target from $14 to $13.

富国银行分析师内森·特雷贝克维持Nevro(纽约证券交易所代码:NVRO)的权重相等,并将目标股价从14美元下调至13美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发